New blood test offers potential for faster, targeted treatment of non-small-cell lung cancer
Credit: Biodesix, Inc. Philadelphia, PA, April 19, 2017 - Identification of a specific genetic mutation in patients with non-small-cell lung cancer (NSCLC) helps clinicians select...






